Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes

AIM/INTRODUCTION: To investigate the differences in the clinical significance and glutamic acid decarboxylase autoantibody (GADA) affinity between RIA (RIA‐GADA) and ELISA (ELISA‐GADA) in patients with type 1 diabetes. METHODS: A total of 415 patients with type 1 diabetes were enrolled, including 19...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawasaki, Eiji, Shimada, Akira, Imagawa, Akihisa, Abiru, Norio, Awata, Takuya, Oikawa, Yoichi, Osawa, Haruhiko, Kawabata, Yumiko, Kozawa, Junji, Kobayashi, Tetsuro, Takahashi, Kazuma, Chujo, Daisuke, Fukui, Tomoyasu, Miura, Junnosuke, Yasuda, Kazuki, Yasuda, Hisafumi, Kajio, Hiroshi, Hanafusa, Toshiaki, Ikegami, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034953/
https://www.ncbi.nlm.nih.gov/pubmed/36691729
http://dx.doi.org/10.1111/jdi.13980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034953/
https://www.ncbi.nlm.nih.gov/pubmed/36691729
http://dx.doi.org/10.1111/jdi.13980

Ejemplares similares